Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Actinium Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Common stock, par value $0.001 per share | Rule 457(c) and Rule 457(h) | 3,500,000 | (2) | $ | 9.03 | (3) | $ | 31,605,000 | $147.60 per $1,000,000 | $ | 4,664.90 | ||||||||||||
| Total Offering Amounts | $ | 31,605,000 | $ | 4,664.90 | ||||||||||||||||||||
| Total Fee Offsets (4) | $ | - | ||||||||||||||||||||||
| Net Fee Due | $ | 4,664.90 | ||||||||||||||||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), we are also registering an indeterminable number of shares of common stock, par value $0.001 per share, as may be issued in connection with stock splits, stock dividends or similar transactions. |
| (2) | Represents shares of common stock issuable pursuant to unissued equity awards under the Actinium Pharmaceuticals, Inc. 2019 Plan, as amended. |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act based on the average of the high and low prices per share of common stock as reported by NYSE American on March 25, 2024. |
| (4) | The Registrant does not have any fee offsets. |